Asthma inflammatory phenotypes show differential microRNA expression in sputum.

BACKGROUND Asthma is classified according to severity and inflammatory phenotype and is likely to be distinguished by specific microRNA (miRNA) expression profiles. OBJECTIVE We sought to associate miRNA expression in sputum supernatants with the inflammatory cell profile and disease severity in asthmatic patients. METHODS We investigated miRNA expression in sputum supernatants of 10 healthy subjects, 17 patients with mild-to-moderate asthma, and 9 patients with severe asthma using high-throughput, stem-loop, reverse transcriptase quantitative real-time PCR miRNA expression profiling (screening cohort, n = 36). Differentially expressed miRNAs were validated in an independent cohort (n = 60; 10 healthy subjects and 50 asthmatic patients). Cellular miRNA origin was examined by using in situ hybridization and reverse transcriptase quantitative real-time PCR. The functional role of miRNAs was assessed by using in silico analysis and in vitro transfecting miRNA mimics in human bronchial epithelial cells. RESULTS In 2 independent cohorts expression of miR-629-3p, miR-223-3p, and miR-142-3p was significantly upregulated in sputum of patients with severe asthma compared with that in healthy control subjects and was highest in patients with neutrophilic asthma. Expression of the 3 miRNAs was associated with sputum neutrophilia, and miR-223-3p and miR-142-3p expression was associated also with airway obstruction (FEV1/forced vital capacity). Expression of miR-629-3p was localized in the bronchial epithelium, whereas miR-223-3p and miR-142-3p were expressed in neutrophils, monocytes, and macrophages. Transfecting human bronchial epithelial cells with miR-629-3p mimic induced epithelial IL-8 mRNA and protein expression. IL-1β and IL-8 protein levels were significantly increased in sputum of patients with severe asthma and were positively associated with sputum neutrophilia. CONCLUSIONS Expression of miR-223-3p, miR-142-3p, and miR-629-3p is increased in sputum of patients with severe asthma and is linked to neutrophilic airway inflammation, suggesting that these miRNAs contribute to this asthma inflammatory phenotype.

[1]  J. Schreiber,et al.  MicroRNA-223 controls susceptibility to tuberculosis by regulating lung neutrophil recruitment. , 2013, The Journal of clinical investigation.

[2]  M. Henket,et al.  Distribution of sputum cellular phenotype in a large asthma cohort: predicting factors for eosinophilic vs neutrophilic inflammation , 2013, BMC Pulmonary Medicine.

[3]  Avrum Spira,et al.  MicroRNAs as modulators of smoking-induced gene expression changes in human airway epithelium , 2009, Proceedings of the National Academy of Sciences.

[4]  I. Adcock,et al.  Airway smooth muscle hyperproliferation is regulated by microRNA-221 in severe asthma. , 2013, American journal of respiratory cell and molecular biology.

[5]  T. Zhu,et al.  miR-223 and miR-142 attenuate hematopoietic cell proliferation, and miR-223 positively regulates miR-142 through LMO2 isoforms and CEBP-β , 2010, Cell Research.

[6]  David Galas,et al.  Gene expression networks in COPD: microRNA and mRNA regulation , 2011, Thorax.

[7]  N. Alexis.  Biomarker sampling of the airways in asthma , 2014, Current opinion in pulmonary medicine.

[8]  S. Phipps,et al.  Elevated expression of the NLRP3 inflammasome in neutrophilic asthma , 2013, European Respiratory Journal.

[9]  J. Douwes,et al.  Identifying leukocyte populations in fresh and cryopreserved sputum using flow cytometry , 2013, Cytometry. Part B, Clinical cytometry.

[10]  D. Morrison,et al.  FBXW7α attenuates inflammatory signalling by downregulating C/EBPδ and its target gene Tlr4 , 2013, Nature Communications.

[11]  H. Lodish,et al.  Micromanagement of the immune system by microRNAs , 2008, Nature Reviews Immunology.

[12]  中尾 光輝,et al.  KEGG(Kyoto Encyclopedia of Genes and Genomes)〔和文〕 (特集 ゲノム医学の現在と未来--基礎と臨床) -- (データベース) , 2000 .

[13]  Anna K Rieger,et al.  NLRP3 Inflammasome Activity Is Negatively Controlled by miR-223 , 2012, The Journal of Immunology.

[14]  Ziv Bar-Joseph,et al.  Gene expression in relation to exhaled nitric oxide identifies novel asthma phenotypes with unique biomolecular pathways. , 2014, American journal of respiratory and critical care medicine.

[15]  I. Oglesby,et al.  Cystic Fibrosis Airway Epithelium ∆ MicroRNA-145 ,-223 , and-494 Is Altered in Transmembrane Conductance Regulator by Regulation of Cystic Fibrosis and , 2013 .

[16]  Y. Bossé,et al.  MicroRNA‐19a enhances proliferation of bronchial epithelial cells by targeting TGFβR2 gene in severe asthma , 2015, Allergy.

[17]  M. Love,et al.  Airway epithelial miRNA expression is altered in asthma. , 2012, American journal of respiratory and critical care medicine.

[18]  Zhiwei Wang,et al.  Down-regulation of miR-223 reverses epithelial-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells , 2015, Oncotarget.

[19]  R. Schubert,et al.  Transforming Growth Factor β1 Genotypes in Relation to TGFβ1, Interleukin-8, and Tumor Necrosis Factor Alpha in Induced Sputum and Blood in Cystic Fibrosis , 2013, Mediators of inflammation.

[20]  Susumu Goto,et al.  Data, information, knowledge and principle: back to metabolism in KEGG , 2013, Nucleic Acids Res..

[21]  D. Knight,et al.  Induction of epithelial-mesenchymal transition in primary airway epithelial cells from patients with asthma by transforming growth factor-beta1. , 2009, American journal of respiratory and critical care medicine.

[22]  V. Capelozzi,et al.  Pleural fluid cytokines correlate with tissue inflammatory expression in tuberculosis. , 2010, The International Journal of Tuberculosis and Lung Disease.

[23]  C. Akdis,et al.  MicroRNAs: Essential players in the regulation of inflammation. , 2013, The Journal of allergy and clinical immunology.

[24]  Jan Hellemans,et al.  miRNA expression profiling: from reference genes to global mean normalization. , 2012, Methods in molecular biology.

[25]  I. Pavord,et al.  Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial , 2002, The Lancet.

[26]  Andreas Günther,et al.  miR-142-3p balances proliferation and differentiation of mesenchymal cells during lung development , 2014, Development.

[27]  William Arbuthnot Sir Lane,et al.  Acetylation of Poly(ADP-ribose) Polymerase-1 by p300/CREB-binding Protein Regulates Coactivation of NF-κB-dependent Transcription* , 2005, Journal of Biological Chemistry.

[28]  David W H Riches,et al.  Corticosteroid-resistant asthma is associated with classical antimicrobial activation of airway macrophages. , 2008, The Journal of allergy and clinical immunology.

[29]  R. Silbajoris,et al.  Distinct microRNA expression in human airway cells of asthmatic donors identifies a novel asthma-associated gene. , 2012, American journal of respiratory cell and molecular biology.

[30]  H. Dweep,et al.  miRWalk2.0: a comprehensive atlas of microRNA-target interactions , 2015, Nature Methods.

[31]  D. Postma,et al.  Expression of vascular remodelling markers in relation to bradykinin receptors in asthma and COPD , 2013, Thorax.

[32]  Kian Fan Chung,et al.  MicroRNA Expression Profiling in Mild Asthmatic Human Airways and Effect of Corticosteroid Therapy , 2009, PloS one.

[33]  Pieter Mestdagh,et al.  High-throughput stem-loop RT-qPCR miRNA expression profiling using minute amounts of input RNA , 2008, Nucleic acids research.

[34]  R. Djukanović,et al.  Nebulised salbutamol administered during sputum induction improves bronchoprotection in patients with asthma , 2004, Thorax.

[35]  Melissa G. Piper,et al.  Macrophage microvesicles induce macrophage differentiation and miR-223 transfer. , 2013, Blood.

[36]  K. Ansel,et al.  A miRNA upregulated in asthma airway T cells promotes TH2 cytokine production , 2014, Nature Immunology.

[37]  J. Vandesompele,et al.  MicroRNA expression in induced sputum of smokers and patients with chronic obstructive pulmonary disease. , 2011, American journal of respiratory and critical care medicine.

[38]  S. Wenzel.  Asthma phenotypes: the evolution from clinical to molecular approaches , 2012, Nature Medicine.

[39]  L. Wood,et al.  Sputum gene expression signature of 6 biomarkers discriminates asthma inflammatory phenotypes. , 2014, The Journal of allergy and clinical immunology.

[40]  R. Scott,et al.  Inflammatory subtypes in asthma: Assessment and identification using induced sputum , 2006, Respirology.

[41]  E. Bleecker,et al.  International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma , 2013, European Respiratory Journal.

[42]  S. Masters,et al.  miR‐223: infection, inflammation and cancer , 2013, Journal of internal medicine.

[43]  M. Zamora,et al.  Functional and genomic changes induced by alveolar transmigration in human neutrophils. , 2006, American journal of physiology. Lung cellular and molecular physiology.

[44]  Donavan T. Cheng,et al.  Expression Profiling of Human Immune Cell Subsets Identifies miRNA-mRNA Regulatory Relationships Correlated with Cell Type Specific Expression , 2012, PloS one.

[45]  C. Bachert,et al.  Sputum IgE and Cytokines in Asthma: Relationship with Sputum Cellular Profile , 2013, PloS one.

[46]  Jun Zhao,et al.  MiR‐142‐3p represses TGF‐β‐induced growth inhibition through repression of TGFβR1 in non‐small cell lung cancer , 2014, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.